Desmopressin cas 16679-58-6

Desmopressin is a synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. It is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels. In hemophilia A and von Willebrand disease, it should only be used for mild to moderate cases. It may be given in the nose, by injection into a vein, by mouth, or under the tongue.

Related Products:

Plecanatide; Linaclotide; Carbetocin; Octreotide acetate; Terlipressin; Cetrorelix; Desmopressin acetate; Degarelix; Goserelin acetate; Ganirelix Acetate; Abarelix; GLP-1 (7-37); Semaglutide

1: Weiss JP, van der Meulen EA, Juul KV. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria. Eur Urol Focus. 2018 Nov 20. pii: S2405-4569(18)30333-X. doi: 10.1016/j.euf.2018.11.001. [Epub ahead of print] PubMed PMID: 30470646.

2: Singh K, Kanodia AK, Ross P, Torgersen A, Maclean J, Leese G, Hossain-Ibrahim K. Xanthomatous hypophysitis causing hypogonadotropic hypogonadism resulting in delayed presentation of slipped capital femoral epiphysis. Br J Neurosurg. 2018 Nov 19:1-4. doi: 10.1080/02688697.2018.1525482. [Epub ahead of print] PubMed PMID: 30450996.